The upregulation of lysosome-associated membrane protein 3 (LAMP3) in patients with NAFLD and in mouse models has been correlated with the activation of the PI3K/Akt pathway, which facilitates autolysosome fusion (188). This evidence concerns the gene AKT1 and metabolic dysfunction-associated steatotic liver disease.